Clinical Trial
Published on 07 Feb 2024
A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
in Cardio-Oncology
![A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin](https://www.frontiersin.org/files/myhome article library/1324203/1324203_Thumb_400.jpg)
- 1,031 views